DE2548340C2 - - Google Patents

Info

Publication number
DE2548340C2
DE2548340C2 DE2548340A DE2548340A DE2548340C2 DE 2548340 C2 DE2548340 C2 DE 2548340C2 DE 2548340 A DE2548340 A DE 2548340A DE 2548340 A DE2548340 A DE 2548340A DE 2548340 C2 DE2548340 C2 DE 2548340C2
Authority
DE
Germany
Prior art keywords
group
benzimidazole
groups
compound
general formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE2548340A
Other languages
German (de)
English (en)
Other versions
DE2548340A1 (de
Inventor
Peder Bernhard Moelndal Se Berntsson
Stig Ake Ingemar Carlsson
Lars Erik Moelnlycke Se Garberg
Ulf Krister Pixbo Se Junggren
Sven Erik Kungsbacka Se Sjoestrand
Gunhild Wika Von Askim Se Wittken Sundell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hassle AB
Original Assignee
Hassle AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to SE7406513A priority Critical patent/SE416649B/xx
Priority to NO75752851A priority patent/NO143222C/no
Priority to FI752327A priority patent/FI63756C/fi
Priority to DK372175AA priority patent/DK140840B/da
Priority to ZA00756600A priority patent/ZA756600B/xx
Priority to CY1125A priority patent/CY1125A/xx
Priority to GB43039/75A priority patent/GB1525958A/en
Priority to IE2313/75A priority patent/IE42451B1/en
Application filed by Hassle AB filed Critical Hassle AB
Priority to DE19752548340 priority patent/DE2548340A1/de
Priority to AT838075A priority patent/AT337697B/de
Priority to CS757458A priority patent/CS196289B2/cs
Priority to NL7513141A priority patent/NL7513141A/xx
Priority to US05/630,916 priority patent/US4045563A/en
Priority to HU75HE00000696A priority patent/HU172653B/hu
Priority to SU752189960A priority patent/SU602118A3/ru
Priority to DD189463A priority patent/DD122534A5/xx
Priority to FR7534910A priority patent/FR2331340A1/fr
Priority to CA239,643A priority patent/CA1055033A/en
Priority to CH1481475A priority patent/CH623814A5/de
Priority to JP50137712A priority patent/JPS5262275A/ja
Priority to FR7616732A priority patent/FR2392021A1/fr
Priority to AT752276A priority patent/AT351524B/de
Publication of DE2548340A1 publication Critical patent/DE2548340A1/de
Priority to DK783659A priority patent/DK365978A/da
Priority to CS786886A priority patent/CS196290B2/cs
Priority to CH976079A priority patent/CH623582A5/de
Priority to FI811747A priority patent/FI65617C/fi
Priority to HK87/82A priority patent/HK8782A/xx
Priority to MY159/82A priority patent/MY8200159A/xx
Application granted granted Critical
Publication of DE2548340C2 publication Critical patent/DE2548340C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/28—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
DE19752548340 1974-05-16 1975-10-29 Benzimidazole, verfahren zu deren herstellung und sie enthaltende mittel Granted DE2548340A1 (de)

Priority Applications (28)

Application Number Priority Date Filing Date Title
SE7406513A SE416649B (sv) 1974-05-16 1974-05-16 Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
FI752327A FI63756C (fi) 1974-05-16 1975-08-15 Foerfarande foer framstaellning av 2-(2-pyridylmetylsulfinyl)-bensimidazolderivat med magsyrasekretionsinhiberande verkan
NO75752851A NO143222C (no) 1974-05-16 1975-08-15 Analogifremgangsmaate for fremstilling av nye substituerte pyridylsulfinyl-benzimidazoler med terapeutisk aktivitet
DK372175AA DK140840B (da) 1974-05-16 1975-08-18 Analogifremgangsmåde til fremstilling af benzimidazolderivater eller syreadditionssalte deraf.
ZA00756600A ZA756600B (en) 1974-05-16 1975-10-20 Gastric acid secretion agents
CY1125A CY1125A (en) 1974-05-16 1975-10-20 2-(heterocaclic asbstituted alkylsulphinyl)-benzinmidazoles and their pharmaceutical compositions
GB43039/75A GB1525958A (en) 1974-05-16 1975-10-20 2-(heterocyclic substituted alkylsulphinyl)-benzimidazoles and their pharmaceutical compositions
IE2313/75A IE42451B1 (en) 1974-05-16 1975-10-23 2-(heterocyclic substituted alkylsulphinyl)-benzimidazoles and their pharmaceutical compositions
DE19752548340 DE2548340A1 (de) 1974-05-16 1975-10-29 Benzimidazole, verfahren zu deren herstellung und sie enthaltende mittel
AT838075A AT337697B (de) 1974-05-16 1975-11-04 Verfahren zur herstellung von neuen benzimidazolderivaten und ihren salzen
CS757458A CS196289B2 (en) 1974-05-16 1975-11-05 Process for preparing new compounds
NL7513141A NL7513141A (nl) 1974-05-16 1975-11-10 Benzimidazoolderivaten en werkwijze voor het be- reiden daarvan alsmede preparaten voor het bein- vloeden van de maagzuursecretie.
US05/630,916 US4045563A (en) 1974-05-16 1975-11-11 Substituted 2-[pyridylalkylenesulfinyl]-benzimidazoles with gastric acid secretion inhibiting effects
HU75HE00000696A HU172653B (hu) 1974-05-16 1975-11-12 Sposob poluchenija zamehhennykh 2-skobka-2-piridil-metil-sul'finil-skobka zakryta-benzimidazolov
SU752189960A SU602118A3 (ru) 1974-05-16 1975-11-13 Способ получени производных бензимидазола или их солей
DD189463A DD122534A5 (US06897227-20050524-C00065.png) 1974-05-16 1975-11-14
FR7534910A FR2331340A1 (fr) 1974-05-16 1975-11-14 Nouveaux derives du benzimidazole, procede pour leur obtention et compositions pharmaceutiques les contenant
CA239,643A CA1055033A (en) 1974-05-16 1975-11-14 2-(2-heterocyclic-methylsulphinyl)-benzimidazole compounds
CH1481475A CH623814A5 (en) 1974-05-16 1975-11-14 Process for the preparation of novel benzimidazoles
JP50137712A JPS5262275A (en) 1974-05-16 1975-11-15 Production of organic compound
FR7616732A FR2392021A1 (fr) 1974-05-16 1976-06-03 Nouveaux derives du benzimidazole et procede pour leur obtention
AT752276A AT351524B (de) 1974-05-16 1976-10-11 Verfahren zur herstellung von neuen benzimida- zolderivaten, ihren salzen und optischen isomeren
DK783659A DK365978A (da) 1974-05-16 1978-08-18 Mellemprodukt til anvendelse ved fremstilling af benzimidazolderivater
CS786886A CS196290B2 (en) 1974-05-16 1978-10-23 Process for preparing new compounds
CH976079A CH623582A5 (en) 1974-05-16 1979-10-31 Process for the preparation of benzimidazoles
FI811747A FI65617C (fi) 1974-05-16 1981-06-04 Mellanprodukt foer framstaellning av magsyrasekretionsinhiberande 2-(2-pyridylmetylsulfinyl)-benzimidazolderivat
HK87/82A HK8782A (en) 1974-05-16 1982-02-25 2-(heterocyclic substituted alkylsulphinyl)-benzimidazoles and their pharmaceutical compositions
MY159/82A MY8200159A (en) 1974-05-16 1982-12-30 2-[heterocylic substituted alkylsulphinyl]-benzimidazoles and their pharmaceutical compositions

Applications Claiming Priority (25)

Application Number Priority Date Filing Date Title
SE7406513A SE416649B (sv) 1974-05-16 1974-05-16 Forfarande for framstellning av foreningar som paverkar magsyrasekretionen
FI752327A FI63756C (fi) 1974-05-16 1975-08-15 Foerfarande foer framstaellning av 2-(2-pyridylmetylsulfinyl)-bensimidazolderivat med magsyrasekretionsinhiberande verkan
NO75752851A NO143222C (no) 1974-05-16 1975-08-15 Analogifremgangsmaate for fremstilling av nye substituerte pyridylsulfinyl-benzimidazoler med terapeutisk aktivitet
DK372175AA DK140840B (da) 1974-05-16 1975-08-18 Analogifremgangsmåde til fremstilling af benzimidazolderivater eller syreadditionssalte deraf.
GB43039/75A GB1525958A (en) 1974-05-16 1975-10-20 2-(heterocyclic substituted alkylsulphinyl)-benzimidazoles and their pharmaceutical compositions
ZA00756600A ZA756600B (en) 1974-05-16 1975-10-20 Gastric acid secretion agents
IE2313/75A IE42451B1 (en) 1974-05-16 1975-10-23 2-(heterocyclic substituted alkylsulphinyl)-benzimidazoles and their pharmaceutical compositions
DE19752548340 DE2548340A1 (de) 1974-05-16 1975-10-29 Benzimidazole, verfahren zu deren herstellung und sie enthaltende mittel
AT838075A AT337697B (de) 1974-05-16 1975-11-04 Verfahren zur herstellung von neuen benzimidazolderivaten und ihren salzen
CS757458A CS196289B2 (en) 1974-05-16 1975-11-05 Process for preparing new compounds
NL7513141A NL7513141A (nl) 1974-05-16 1975-11-10 Benzimidazoolderivaten en werkwijze voor het be- reiden daarvan alsmede preparaten voor het bein- vloeden van de maagzuursecretie.
US05/630,916 US4045563A (en) 1974-05-16 1975-11-11 Substituted 2-[pyridylalkylenesulfinyl]-benzimidazoles with gastric acid secretion inhibiting effects
HU75HE00000696A HU172653B (hu) 1974-05-16 1975-11-12 Sposob poluchenija zamehhennykh 2-skobka-2-piridil-metil-sul'finil-skobka zakryta-benzimidazolov
SU752189960A SU602118A3 (ru) 1974-05-16 1975-11-13 Способ получени производных бензимидазола или их солей
FR7534910A FR2331340A1 (fr) 1974-05-16 1975-11-14 Nouveaux derives du benzimidazole, procede pour leur obtention et compositions pharmaceutiques les contenant
DD189463A DD122534A5 (US06897227-20050524-C00065.png) 1974-05-16 1975-11-14
CA239,643A CA1055033A (en) 1974-05-16 1975-11-14 2-(2-heterocyclic-methylsulphinyl)-benzimidazole compounds
CH1481475A CH623814A5 (en) 1974-05-16 1975-11-14 Process for the preparation of novel benzimidazoles
JP50137712A JPS5262275A (en) 1974-05-16 1975-11-15 Production of organic compound
FR7616732A FR2392021A1 (fr) 1974-05-16 1976-06-03 Nouveaux derives du benzimidazole et procede pour leur obtention
AT752276A AT351524B (de) 1974-05-16 1976-10-11 Verfahren zur herstellung von neuen benzimida- zolderivaten, ihren salzen und optischen isomeren
DK783659A DK365978A (da) 1974-05-16 1978-08-18 Mellemprodukt til anvendelse ved fremstilling af benzimidazolderivater
CS786886A CS196290B2 (en) 1974-05-16 1978-10-23 Process for preparing new compounds
HU8782 1982-02-25
MY159/82A MY8200159A (en) 1974-05-16 1982-12-30 2-[heterocylic substituted alkylsulphinyl]-benzimidazoles and their pharmaceutical compositions

Publications (2)

Publication Number Publication Date
DE2548340A1 DE2548340A1 (de) 1977-05-05
DE2548340C2 true DE2548340C2 (US06897227-20050524-C00065.png) 1987-12-03

Family

ID=40486266

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752548340 Granted DE2548340A1 (de) 1974-05-16 1975-10-29 Benzimidazole, verfahren zu deren herstellung und sie enthaltende mittel

Country Status (22)

Country Link
US (1) US4045563A (US06897227-20050524-C00065.png)
JP (1) JPS5262275A (US06897227-20050524-C00065.png)
AT (2) AT337697B (US06897227-20050524-C00065.png)
CA (1) CA1055033A (US06897227-20050524-C00065.png)
CH (2) CH623814A5 (US06897227-20050524-C00065.png)
CS (2) CS196289B2 (US06897227-20050524-C00065.png)
CY (1) CY1125A (US06897227-20050524-C00065.png)
DD (1) DD122534A5 (US06897227-20050524-C00065.png)
DE (1) DE2548340A1 (US06897227-20050524-C00065.png)
DK (2) DK140840B (US06897227-20050524-C00065.png)
FI (2) FI63756C (US06897227-20050524-C00065.png)
FR (2) FR2331340A1 (US06897227-20050524-C00065.png)
GB (1) GB1525958A (US06897227-20050524-C00065.png)
HK (1) HK8782A (US06897227-20050524-C00065.png)
HU (1) HU172653B (US06897227-20050524-C00065.png)
IE (1) IE42451B1 (US06897227-20050524-C00065.png)
MY (1) MY8200159A (US06897227-20050524-C00065.png)
NL (1) NL7513141A (US06897227-20050524-C00065.png)
NO (1) NO143222C (US06897227-20050524-C00065.png)
SE (1) SE416649B (US06897227-20050524-C00065.png)
SU (1) SU602118A3 (US06897227-20050524-C00065.png)
ZA (1) ZA756600B (US06897227-20050524-C00065.png)

Families Citing this family (125)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN148930B (US06897227-20050524-C00065.png) * 1977-09-19 1981-07-25 Hoffmann La Roche
AT406119B (de) * 1978-04-14 2000-02-25 Haessle Ab Verfahren zur herstellung von granulaten bzw. tabletten oder kapseln zur oralen verabreichung
AT375365B (de) * 1978-04-14 1984-07-25 Haessle Ab Verfahren zur herstellung von neuen 2-pyridylalkyl-sulfinyl-benzimidazolen, von deren hydraten, stereoisomeren und salzen
SE7804231L (sv) * 1978-04-14 1979-10-15 Haessle Ab Magsyrasekretionsmedel
US4359465A (en) * 1980-07-28 1982-11-16 The Upjohn Company Methods for treating gastrointestinal inflammation
CH644116A5 (de) * 1980-08-21 1984-07-13 Hoffmann La Roche Imidazolderivate.
ZA825106B (en) * 1981-08-13 1983-04-27 Haessle Ab Novel pharmaceutical compositions
US4472409A (en) * 1981-11-05 1984-09-18 Byk Gulden Lomberg Chemische Fabrik Gesellschaft Mit Beschrankter Haftung 2-Pyridylmethyl thio(sulfinyl)benzimidazoles with gastric acid secretion inhibiting effects
KR840002371A (ko) * 1981-11-05 1984-06-25 귄터 미카엘, 헤르페르트 수키 치환된 벤즈 이미다졸의 제조방법
DE3216843C2 (de) * 1982-05-05 1986-10-23 Ludwig Heumann & Co GmbH, 8500 Nürnberg 3-Thiomethyl-pyridin-Derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
SE8300736D0 (sv) * 1983-02-11 1983-02-11 Haessle Ab Novel pharmacologically active compounds
SE8301182D0 (sv) * 1983-03-04 1983-03-04 Haessle Ab Novel compounds
HU191756B (en) * 1983-05-03 1987-04-28 Byk Gulden Lomberg Chem Fab Process for preparing new fluoro-alkoxy-benzimidazole derivatives
IL71664A (en) * 1983-05-03 1987-11-30 Byk Gulden Lomberg Chem Fab Fluoroalkoxy compounds,process for their preparation and pharmaceutical compositions containing the same
US5077407A (en) * 1983-07-01 1991-12-31 The Upjohn Company Substituted 2-[monoannelated (3,4-,4,5-, and 5,6-) pyridylalkylenesulfinyl]benzimidazoles
CA1259070A (en) * 1983-07-01 1989-09-05 Upjohn Company (The) Substituted 2-¬monoannelated(3,4-,4,5-, and 5,6-)- pyridylalkylenesulfinyl|-benzimidazoles
DE3333314A1 (de) * 1983-09-15 1985-03-28 Hoechst Ag, 6230 Frankfurt Substituierte pyrido(1,2-c)imidazo(1,2-a)benzimidazole, verfahren zu ihrer herstellung, ihre verwendung sowie pharmazeutische praeparate auf basis dieser verbindungen
US4575554A (en) * 1983-12-05 1986-03-11 The Upjohn Company Substituted 2-pyridylmethylthio- and sulfinyl-benzimidazoles as gastric antisecretory agents
PH23995A (en) * 1984-01-09 1990-02-09 Janssen Pharmaceutica Nv 4((bicycle heterocyclyl)-methyl and hetero)piperidines
DE3585252D1 (de) * 1984-07-06 1992-03-05 Fisons Plc Benzimidazole, und verfahren zu deren herstellung, deren formulierung und verwendung als magensaeuresekretionshemmende verbindungen.
SE8404065D0 (sv) * 1984-08-10 1984-08-10 Haessle Ab Novel biologically active compounds
JPS6150978A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
JPS6150979A (ja) * 1984-08-16 1986-03-13 Takeda Chem Ind Ltd ピリジン誘導体およびその製造法
US4619997A (en) * 1984-09-06 1986-10-28 The Upjohn Company Substituted 2-pyridylmethylthio and sulfinyl-benzimidazoles as gastric antisecretory agents
KR890000387B1 (ko) * 1984-09-24 1989-03-16 디 엎존 캄파니 2-(피리딜알켄술 피닐)벤즈 이미드아졸류의 n-치환 유도체의 제조방법
AU568441B2 (en) * 1984-09-24 1987-12-24 Upjohn Company, The 2-(pyridylalkenesulfinyl) benzimidazole derivatives
DE3579436D1 (de) * 1984-12-18 1990-10-04 Otsuka Pharma Co Ltd Tetrahydrochinolin- derivate, verfahren zu deren herstellung und diese enthaltende antimagengeschwuerzusammensetzungen.
GB8526154D0 (en) * 1985-02-06 1985-11-27 Kotobuki Seiyaku Co Ltd 2-substituted cyclo-heptoimidazoles
DK8600939A (US06897227-20050524-C00065.png) * 1985-03-05 1986-09-06
FI861772A (fi) * 1985-05-07 1986-11-08 Chemie Linz Ag Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning.
US5869513A (en) * 1985-05-24 1999-02-09 G. D. Searle & Co. 2- (1H-benzimidazol-2-ylsulfinyl)methyl!benzenamines
AU5768886A (en) 1985-05-24 1986-11-27 G.D. Searle & Co. 2-((1-h-benzimidazol-2-ylsulfinyl)methyl)benzenamines
US4738975A (en) * 1985-07-02 1988-04-19 Takeda Chemical Industries, Ltd. Pyridine derivatives, and use as anti-ulcer agents
DK337086A (da) * 1985-08-12 1987-02-13 Hoffmann La Roche Benzimidazolderivater
AR243167A1 (es) 1985-08-24 1993-07-30 Hoechst Ag Procedimiento para la preparacion de toluidinas sustituidas.
SE8505112D0 (sv) * 1985-10-29 1985-10-29 Haessle Ab Novel pharmacological compounds
US5433959A (en) * 1986-02-13 1995-07-18 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
US6749864B2 (en) * 1986-02-13 2004-06-15 Takeda Chemical Industries, Ltd. Stabilized pharmaceutical composition
SE8600658D0 (sv) * 1986-02-14 1986-02-14 Haessle Ab Novel composition of matter
DE3777855D1 (de) 1986-02-20 1992-05-07 Hoechst Ag Substituierte thienoimidazol-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer.
WO1987005296A1 (en) * 1986-03-07 1987-09-11 Pfizer Inc. 2-[(2-pyridyl)methylsulfinyl]thienoimidazoles and related compounds as antiulcer agents
EP0239129B1 (en) * 1986-03-28 1991-09-25 Otsuka Pharmaceutical Co., Ltd. Hydroquinoline compounds, compositions containing same and processes for preparing same
US4687775A (en) * 1986-07-17 1987-08-18 G. D. Searle & Co. 2-[(Imidazo[1,2-a]pyridinylmethyl)sulfinyl]-1H-benzimidazoles
US4772619A (en) * 1986-07-17 1988-09-20 G. D. Searle & Co. [(1H-benzimidazol-2-ylsulfinyl)methyl]-2-pyridinamines
US4721718A (en) * 1986-08-18 1988-01-26 G. D. Searle & Co. 2-[(imidazo[1,2-a]pyridin-3-ylmethyl)sulfinyl]-1H-benzimidazoles useful in the treatment and prevention of ulcers
SE8604998D0 (sv) 1986-11-21 1986-11-21 Haessle Ab Novel pharmacological compounds
NZ222495A (en) 1986-11-21 1991-04-26 Haessle Ab Benzimidazole derivatives and pharmaceutical compositions
DE3639926A1 (de) * 1986-11-22 1988-06-01 Hoechst Ag Substituierte thienoimidazoltoluidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer
GB8630080D0 (en) * 1986-12-17 1987-01-28 Glaxo Group Ltd Medicaments
US5330982A (en) * 1986-12-17 1994-07-19 Glaxo Group Limited Pharmaceutical composition containing a 5-HT receptor antagonist and an H+ K+ Atpase inhibitor and a method of treating gastrointestingal disorders therewith
DE3723327A1 (de) * 1987-07-15 1989-02-02 Hoechst Ag Substituierte thienoimidazol-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer, magenschutzmittel sowie als medikament gegen intestinale entzuendungen
HU886738D0 (en) * 1987-10-30 1990-02-28 Haessle Ab Process for the preparation of pharmaceutical compositions against osteoporosis containing 2-pyridinyl-methyl-(sulfinyl or thio)-benzimidazoles
KR920003928B1 (ko) * 1988-09-20 1992-05-18 히사미쯔세이야꾸 가부시기가이샤 신규의 디벤즈[b,e]옥세핀유도체
EG19302A (en) * 1988-12-22 1994-11-30 Haessle Ab Compound with gastric acid inhibitory effect and process for its preparation
SE8804628D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New compounds
SE8804629D0 (sv) 1988-12-22 1988-12-22 Ab Haessle New therapeutically active compounds
ATE110069T1 (de) * 1989-11-29 1994-09-15 Toa Eiyo Ltd Cycloheptenopyridinderivate, verfahren zu ihrer herstellung und diese enthaltende antiulkusmitteln.
US5049674A (en) 1989-12-20 1991-09-17 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
US4965269A (en) * 1989-12-20 1990-10-23 Ab Hassle Therapeutically active chloro substituted benzimidazoles
US5274099A (en) * 1989-12-20 1993-12-28 Aktiebolaget Hassle Therapeutically active fluoro substituted benzimidazoles
JP2524420B2 (ja) * 1990-05-16 1996-08-14 明治製菓株式会社 ピペリジン誘導体及びそれらを有効成分とする抗潰瘍剤
SE9002206D0 (sv) 1990-06-20 1990-06-20 Haessle Ab New compounds
US5364875A (en) * 1992-05-11 1994-11-15 The Du Pont Merck Pharmaceutical Company Imidazoles linked to bicyclic heterocyclic groups for the treatment of atherosclerosis
RU95105442A (ru) * 1992-07-08 1997-02-20 Монсанто Компани (US) Способ лечения язвы желудка у свиней, изделие для лечения язвы желудка у свиней
NZ254237A (en) * 1992-07-28 1995-12-21 Astra Ab Injectable solution of a 2-[(2-pyridyl)methylsulphinyl]-benzimidazole or a salt thereof; an injection kit
TW280770B (US06897227-20050524-C00065.png) 1993-10-15 1996-07-11 Takeda Pharm Industry Co Ltd
WO1995029897A1 (en) 1994-04-29 1995-11-09 G.D. Searle & Co. METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS
EP0849259A4 (en) 1995-07-17 1998-11-11 Fuji Photo Film Co Ltd BENZIMIDAZOLE COMPOUNDS
US5824339A (en) * 1995-09-08 1998-10-20 Takeda Chemical Industries, Ltd Effervescent composition and its production
AU6998796A (en) * 1995-09-21 1997-04-28 Pharma Pass Llc Novel composition containing an acid-labile benzimidazole and process for its preparation
DE69814862T2 (de) * 1997-07-11 2004-02-19 Eisai Co., Ltd. Verfahren zur herstellung von pyridinderivaten
US6096340A (en) * 1997-11-14 2000-08-01 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6174548B1 (en) 1998-08-28 2001-01-16 Andrx Pharmaceuticals, Inc. Omeprazole formulation
GB9805558D0 (en) * 1998-03-17 1998-05-13 Knoll Ag Chemical process`
ES2274625T3 (es) 1998-05-18 2007-05-16 Takeda Pharmaceutical Company Limited Comprimidos desintegrables en la boca que comprenden un bencimidazol.
US6093734A (en) * 1998-08-10 2000-07-25 Partnership Of Michael E. Garst, George Sachs, And Jai Moo Shin Prodrugs of proton pump inhibitors
JP4346243B2 (ja) * 1998-08-10 2009-10-21 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア プロトン・ポンプ・インヒビターのプロドラッグ
US6166213A (en) * 1998-08-11 2000-12-26 Merck & Co., Inc. Omeprazole process and compositions thereof
US6733778B1 (en) * 1999-08-27 2004-05-11 Andrx Pharmaceuticals, Inc. Omeprazole formulation
US6852739B1 (en) 1999-02-26 2005-02-08 Nitromed Inc. Methods using proton pump inhibitors and nitric oxide donors
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
AU5424500A (en) 2000-02-24 2001-09-03 Kopran Res Lab Ltd Orally administrable acid stable anti-ulcer benzimidazole derivatives
US6544556B1 (en) 2000-09-11 2003-04-08 Andrx Corporation Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
AU2001296908A1 (en) * 2000-09-29 2002-04-08 Geneva Pharmaceuticals, Inc. Proton pump inhibitor formulation
WO2003027098A1 (fr) * 2001-09-25 2003-04-03 Takeda Chemical Industries, Ltd. Compose de benzymidazole, procede de production et d'utilisation de celui-ci
WO2003032953A1 (fr) 2001-10-17 2003-04-24 Takeda Chemical Industries, Ltd. Granules contenant un agent chimique instable en milieu acide, en concentration elevee
US20030228363A1 (en) * 2002-06-07 2003-12-11 Patel Mahendra R. Stabilized pharmaceutical compositons containing benzimidazole compounds
AU2003242388A1 (en) * 2002-06-14 2003-12-31 Takeda Pharmaceutical Company Limited Prodrug and process for producing the same
AU2003259154B2 (en) * 2002-07-19 2006-12-07 The Regents Of The University Of California Benzimidazole derivatives and their use as prodrugs of proton pump inhibitor
EP1534278A4 (en) * 2002-08-01 2006-09-06 Nitromed Inc NITROSED PROTONATE PUMP INHIBITORS, COMPOSITIONS AND USE METHOD
MY148805A (en) 2002-10-16 2013-05-31 Takeda Pharmaceutical Controlled release preparation
EP2596792A1 (en) 2002-10-16 2013-05-29 Takeda Pharmaceutical Company Limited Stable solid preparations
WO2004112756A1 (en) 2003-06-26 2004-12-29 Isa Odidi Proton pump-inhibitor-containing capsules which comprise subunits differently structured for a delayed release of the active ingredient
WO2005020954A2 (en) * 2003-09-03 2005-03-10 Agi Therapeutics Limited Proton pump inhibitor formulations, and methods of preparing and using such formulations
WO2005039640A1 (en) * 2003-10-03 2005-05-06 Allergan Inc. Compositions comprising trefoil factor family peptides and/or mucoadhesives and proton pump inhibitor prodrugs
US20050075371A1 (en) * 2003-10-03 2005-04-07 Allergan, Inc. Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
US20070292498A1 (en) * 2003-11-05 2007-12-20 Warren Hall Combinations of proton pump inhibitors, sleep aids, buffers and pain relievers
EP1716136A1 (en) 2004-02-11 2006-11-02 Ulkar Kimya Sanayii Ve Ticaret A.S. Pyridine benzimidazole sulfoxides of high purity
EP1715861A2 (en) * 2004-02-18 2006-11-02 Allergan, Inc. Compositions comprising prodrugs of proton pump inhibitors
AU2005216863A1 (en) * 2004-02-18 2005-09-09 Allergan, Inc. Methods and compositions for the intravenous administration of compounds related to proton pump inhibitors
MXPA06011820A (es) * 2004-04-16 2006-12-15 Santarus Inc Combinacion de inhibidor de bomba de proton, agente regulador del ph y agente procinetico.
US8394409B2 (en) 2004-07-01 2013-03-12 Intellipharmaceutics Corp. Controlled extended drug release technology
US20060024362A1 (en) 2004-07-29 2006-02-02 Pawan Seth Composition comprising a benzimidazole and process for its manufacture
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
KR101376360B1 (ko) 2004-09-13 2014-03-20 다케다 야쿠힌 고교 가부시키가이샤 산화 화합물 제조 방법 및 제조 장치
WO2006090845A1 (ja) 2005-02-25 2006-08-31 Takeda Pharmaceutical Company Limited 顆粒の製造方法
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
WO2007074856A1 (ja) 2005-12-28 2007-07-05 Takeda Pharmaceutical Company Limited 口腔内崩壊性固形製剤の製造法
US20070199890A1 (en) * 2006-02-27 2007-08-30 Agion Technologies, Inc. Antimicrobial activated carbon and use thereof
US9561188B2 (en) 2006-04-03 2017-02-07 Intellipharmaceutics Corporation Controlled release delivery device comprising an organosol coat
US10960077B2 (en) * 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
US7786309B2 (en) * 2006-06-09 2010-08-31 Apotex Pharmachem Inc. Process for the preparation of esomeprazole and salts thereof
US20100317689A1 (en) * 2006-09-19 2010-12-16 Garst Michael E Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
GB2444593B (en) 2006-10-05 2010-06-09 Santarus Inc Novel formulations for immediate release of proton pump inhibitors and methods of using these formulations
US20080103169A1 (en) 2006-10-27 2008-05-01 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
EP3628307A1 (en) 2006-12-22 2020-04-01 Ironwood Pharmaceuticals, Inc. Compositions comprising bile acid sequestrants for treating esophageal disorders
WO2012027331A1 (en) 2010-08-27 2012-03-01 Ironwood Pharmaceuticals, Inc. Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
WO2013031620A1 (ja) 2011-08-26 2013-03-07 国立大学法人名古屋大学 骨形成促進剤及びその用途
CN104114169A (zh) 2011-12-16 2014-10-22 阿托佩斯治疗有限公司 用于治疗嗜酸细胞性食管炎的crth2拮抗剂和质子泵抑制剂的组合物
CA2898362C (en) 2013-01-15 2020-09-01 Ironwood Pharmaceuticals, Inc. Gastro-retentive sustained-release oral dosage form of a bile acid sequestrant
WO2016126625A1 (en) 2015-02-03 2016-08-11 Ironwood Pharmaceuticals, Inc. Methods of treating upper gastrointestinal disorders in ppi refractory gerd
US20170042806A1 (en) 2015-04-29 2017-02-16 Dexcel Pharma Technologies Ltd. Orally disintegrating compositions
US10736855B2 (en) 2016-02-25 2020-08-11 Dexcel Pharma Technologies Ltd. Compositions comprising proton pump inhibitors
US10076494B2 (en) 2016-06-16 2018-09-18 Dexcel Pharma Technologies Ltd. Stable orally disintegrating pharmaceutical compositions
WO2024075017A1 (en) 2022-10-04 2024-04-11 Zabirnyk Arsenii Inhibition of aortic valve calcification

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1234058A (US06897227-20050524-C00065.png) * 1968-10-21 1971-06-03
DE1903755B2 (de) * 1969-01-25 1971-04-22 Th Goldschmidt AG, 4300 Essen Verfahren zur herstellung von zinnhaltigen keramischen farbkoerpern
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan

Also Published As

Publication number Publication date
JPS6128673B2 (US06897227-20050524-C00065.png) 1986-07-01
DE2548340A1 (de) 1977-05-05
AT351524B (de) 1979-07-25
SE7406513L (sv) 1975-11-17
IE42451B1 (en) 1980-08-13
CA1055033A (en) 1979-05-22
NO143222B (no) 1980-09-22
ZA756600B (en) 1976-09-29
FR2392021B1 (US06897227-20050524-C00065.png) 1979-08-17
GB1525958A (en) 1978-09-27
MY8200159A (en) 1982-12-31
DK140840B (da) 1979-11-26
CS196290B2 (en) 1980-03-31
FI63756B (fi) 1983-04-29
FI63756C (fi) 1983-08-10
DK365978A (da) 1978-08-18
SU602118A3 (ru) 1978-04-05
CH623814A5 (en) 1981-06-30
HU172653B (hu) 1978-11-28
FI65617C (fi) 1984-06-11
FR2331340B1 (US06897227-20050524-C00065.png) 1979-01-19
ATA838075A (de) 1976-11-15
NO143222C (no) 1981-01-02
CS196289B2 (en) 1980-03-31
US4045563A (en) 1977-08-30
NL7513141A (nl) 1977-05-12
AT337697B (de) 1977-07-11
FR2331340A1 (fr) 1977-06-10
CY1125A (en) 1982-02-19
DK372175A (US06897227-20050524-C00065.png) 1977-02-19
NO752851L (US06897227-20050524-C00065.png) 1977-02-16
FI65617B (fi) 1984-02-29
ATA752276A (de) 1979-01-15
DK140840C (US06897227-20050524-C00065.png) 1980-05-05
CH623582A5 (en) 1981-06-15
HK8782A (en) 1982-03-05
FR2392021A1 (fr) 1978-12-22
DD122534A5 (US06897227-20050524-C00065.png) 1976-10-12
SE416649B (sv) 1981-01-26
FI811747L (fi) 1981-06-04
FI752327A (US06897227-20050524-C00065.png) 1977-02-16
JPS5262275A (en) 1977-05-23

Similar Documents

Publication Publication Date Title
DE2548340C2 (US06897227-20050524-C00065.png)
DD142882A5 (de) Verfahren zur herstellung von pyridylmethylsulfinylbenzimidazolen
EP0001279B1 (de) Imidazolderivate deren Herstellung und diese enthaltende Präparate
DE2504252C2 (US06897227-20050524-C00065.png)
DD252375A5 (de) Verfahren zur herstellung von benzimidazolderivaten
DD202876A5 (de) Verfahren zur herstellung von 2-pyridylmethylthiobenzimidazolen
CH627465A5 (de) Verfahren zur herstellung von benzisothiazolonen.
DE19513048C2 (de) Neue 5-Pyrrolyl-6-halogen-2-pyridylmethylsulfinylbenzimidazol-Derivate
DD218364A5 (de) Verfahren zur herstellung von 3-(amino- oder subst.-amino)-4-(subst.-amino)-1,2,5-thiadiazol verbindungen
DE3509333A1 (de) Substituierte benzimidazolderivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer
DE4313690A1 (de) Kondensierte Chinolyl-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
CH626871A5 (US06897227-20050524-C00065.png)
EP0037471B1 (de) 1-Aroyl-2-phenylamino-2-imidazoline, ihre Herstellung und diese enthaltende Arzneimittel
AT374473B (de) Verfahren zur herstellung von neuen 2-pyridylalkylthio-benzimidazolen sowie von deren hydraten, stereoisomeren und salzen
AT374472B (de) Verfahren zur herstellung von neuen 2-pyridylalkylthio-benzimidazolen sowie von deren hydraten, stereoisomeren und salzen
AT406119B (de) Verfahren zur herstellung von granulaten bzw. tabletten oder kapseln zur oralen verabreichung
DE3726381A1 (de) Guanidincarbonsaeureester, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4313697A1 (de) Chinolyl-dihydropyridinester, Verfahren zu ihrer Herstellung und ihre Verwendung in Arzneimitteln
AT375365B (de) Verfahren zur herstellung von neuen 2-pyridylalkyl-sulfinyl-benzimidazolen, von deren hydraten, stereoisomeren und salzen
DE2753391A1 (de) Benzisothiazolone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneipraeparate
AT357524B (de) Verfahren zur herstellung von neuen benziso- thiazolonen und deren saeureadditionssalzen
CS261874B2 (cs) Způsob výroby 2-pyridylmethylsulfinylbenzimidazolů
DD270531A5 (de) Verfahren zur herstellung von benzimidazolen

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee